SHIVALIK RASAYAN LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 672.8 INR | -2.56% |
|
+20.44% | -9.67% |
| Sales 2022 | 2.07B 24.79M | Sales 2023 | 2.34B 28.03M | Capitalization | 9.74B 117M |
|---|---|---|---|---|---|
| Net income 2022 | 256M 3.07M | Net income 2023 | 212M 2.54M | EV / Sales 2022 | 6.39 x |
| Net cash position 2022 | 296M 3.55M | Net Debt 2023 | 348M 4.17M | EV / Sales 2023 | 4.31 x |
| P/E ratio 2022 |
51.5
x | P/E ratio 2023 |
45.9
x | Employees | 256 |
| Yield 2022 |
0.05% | Yield 2023 |
0.07% | Free-Float | 40.84% |
More Fundamentals
* Assessed data
More news
| 1 day | -3.04% | ||
| 1 week | +20.44% | ||
| Current month | +15.92% | ||
| 1 month | +17.41% | ||
| 3 months | +1.99% | ||
| 6 months | -4.44% | ||
| Current year | -9.67% |
1 week
554.30
726.00
1 month
551.25726.00
Current year
498.00774.60
1 year
498.00890.05
3 years
498.001 196.80
5 years
174.301 196.80
10 years
7.001 196.80
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 62 | 17/18/17 | |
Vinod Kumar
DFI | Director of Finance/CFO | - | 01/01/01 |
Parul Choudhary
CMP | Compliance Officer | - | 01/17/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Sanjay Bansal
BRD | Director/Board Member | 59 | - |
| Chief Executive Officer | 62 | 17/18/17 | |
Rahul Bishnoi
FOU | Founder | 59 | 16/79/16 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/24/30 | 672.8 | -2.56% | 19 120 |
| 29/24/29 | 690.5 | +19.99% | 46,830 |
| 26/24/26 | 575.4 | +2.86% | 2,274 |
| 25/24/25 | 559.4 | -0.12% | 1,937 |
| 24/24/24 | 560.2 | +0.76% | 325 |
Delayed Quote Bombay S.E., April 30, 2024 at 11:16 am IST
More quotes
Shivalik Rasayan Limited is a manufacturer of agrochemicals and active pharma ingredients (API). The Companyâs segments include agrochemicals, API, and pharma formulation. It is the producer of Malathion Technical and Dimethoate Technical. Malathion Technical is a non-systemic, wide spectrum organophosphorus (OP) based contact insecticide. Dimethoate Technical is used in preparation of formulations used in the control of a range of insects and mites. It also manufactures organophosphorus-based insecticides and chemicals. It has a diverse product range and product mix in order to serve consumer requirements. The APIs are being developed and manufactured in the niche area of oncology, ARVs, cardiovascular, metabolic disorders and immunology. It offers solutions from product selection to development to commercialization for a range of oncology and non-oncology products. The Companyâs oncology products include Azacitidine, Busulfan, Bortezomib, and various others.
Sector
Agricultural Chemicals
Calendar
29/05/2024
- Q4 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -9.67% | 129M | |
| +15.82% | 38.79B | |
| -.--% | 10.98B | |
| -4.50% | 7.52B | |
| +3.10% | 6.81B | |
| -3.91% | 6B | |
| -10.77% | 5.59B | |
| -4.54% | 5.66B | |
| +33.14% | 5.26B | |
| -13.64% | 4.56B |
- Stock Market
- Equities
- SHIVALIK Stock
